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A new pharmacological preconditioning-based target: 
from drosophila to kidney transplantation
Michel Tauc1*, Nicolas Melis1*, Miled Bourourou2, Sébastien Giraud3, Thierry Hauet3, 
and Nicolas Blondeau2
One of the biggest challenges in medicine is to dampen the pathophysiological stress induced by an 
episode of ischemia. Such stress, due to various pathological or clinical situations, follows a restriction 
in blood and oxygen supply to tissue, causing a shortage of oxygen and nutrients that are required 
for cellular metabolism. Ischemia can cause irreversible damage to target tissue leading to a poor 
physiological recovery outcome for the patient. Contrariwise, preconditioning by brief periods of 
ischemia has been shown in multiple organs to confer tolerance against subsequent normally lethal 
ischemia. By definition, preconditioning of organs must be applied preemptively. This limits the 
applicability of preconditioning in clinical situations, which arise unpredictably, such as myocardial 
infarction and stroke. There are, however, clinical situations that arise as a result of ischemia-reperfusion 
injury, which can be anticipated, and are therefore adequate candidates for preconditioning. Organ and 
more particularly kidney transplantation, the optimal treatment for suitable patients with end stage renal 
disease (ESRD), is a predictable surgery that permits the use of preconditioning protocols to prepare the 
organ for subsequent ischemic/reperfusion stress. It therefore seems crucial to develop appropriate 
preconditioning protocols against ischemia that will occur under transplantation conditions, which up 
to now mainly referred to mechanical ischemic preconditioning that triggers innate responses. It is not 
known if preconditioning has to be applied to the donor, the recipient, or both. No drug/target pair has 
been envisioned and validated in the clinic. Options for identifying new target/drug pairs involve the use 
of model animals, such as drosophila, in which some physiological pathways, such as the management 
of oxygen, are highly conserved across evolution. Oxygen is the universal element of life existence on 
earth. In this review we focus on a very specific pathway of pharmacological preconditioning identified 
in drosophila that was successfully transferred to mammalian models that has potential application in 
human health. Very few mechanisms identified in these model animals have been translated to an upper 
evolutionary level. This review highlights the commonality between oxygen regulation between diverse 
animals.
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Introduction
Organ transplantation is characterized by an unavoidable 
episode of ischemia/reperfusion (IR), which is one of the 
main causes for impairment in graft functional recovery and 
poor patient outcome. Kidney transplantation has become an 
established worldwide practice replacing the endless dialysis 
strategy that negatively affects a patient's well-being and 
finances. For many years clinicians have been looking for any 
way to reduce the ischemia induced renal stress that occurs 
after reperfusion, which decreases the optimal functional 
recovery of the graft (Khalifeh et al., 2015). Unfortunately, 
very few protocols addressing this particular ischemic situation 
have been transferred to the human clinic. This lack of clinical 
translation is probably due to the multifactorial causes of the 
ischemia/reperfusion-induced injury.
While ischemic injuries of the brain and heart are 
unpredictable in their onset, organ transplantation is a scheduled 
surgical procedure. The predictability of organ transplantation 
therefore facilitates the use of protective preconditioning 
strategies either on the donor, the recipient, or on the isolated 
organ. It should however be borne in mind that while 
preconditioning is logistically straightforward in the case of 
elective living donor kidney transplantation, in deceased donor 
transplantation, preconditioning is much more of a challenge 
as the timing is unpredictable and the donor and recipient are 
often in different hospitals. In this situation the most effective 
protocol often tested at the preclinical level is ischemic 
preconditioning (IPC), as applied on the kidney (Toosy et al., 
1999). Basically the principle of this method is to apply brief 
repeated occlusions of the arteries irrigating the organ in order 
to induce a protective response against a subsequent prolonged 
potentially lethal occlusion. Derived from IPC, remote ischemic 
preconditioning (RIPC) confers a global protective effect and 
renders remote organs resistant to IR injury through various 
transduction signals, mediators, and effectors that have been 
recently reviewed (Hausenloy et al., 2016; Stokfisz et al., 2017). 
Despite the promising results described in animal models (Torras 
et al., 2002; Soendergaard et al., 2012; Yoon et al., 2015) it 
is difficult to draw clear conclusions regarding the potential 
benefit of ischemic conditioning in clinical trials (MacAllister 
et al., 2015; Nadarajah et al., 2017; Veighey, 2018). Various IPC 
and RIPC protocols have been used in these clinical trials either 
on the donor or the recipient. As the mechanism underlining 
the preconditioning effect has not yet been fully elucidated 
it is more difficult to plan the most effective and appropriate 
intervention in the clinical setting. A review of the existing 
clinical trials literature in this area highlights the potential of 
RIPC in kidney transplantation (Veighey and MacAllister, 
Figure 1. Schema of the urea cycle involved in the catabolism of amino acids leading to polyamines synthesis through sequential enzymatic 
catalysis. Survivorship of flies maintained under hypoxia depends on the amino acid content of the diet. Inhibition of ornithine decarboxylase 
with DFMO suppresses the toxic effects of a casein diet or of ornithine added to a glucose protein free diet on hypoxic flies’ longevity. The 
polyamines putrescine and spermidine remained deleterious in the presence of DFMO. By contrast inhibition of DHS with GC7 strongly 
prevented the deleterious actions of casein, amino acids, and polyamines on flies’ survival under hypoxic conditions. The survivorship of 
hypoxic flies maintained on a casein diet was enhanced by 72% in the presence of GC7. A log rank test was used to compare survivorship 
curves. **: p < 0.0001. DHS: deoxyhypusine synthase, DOHH: deoxyhypusine synthase, DFMO: α-difluoromethylornithine, GC7: N1-guanyl-1,7-
diaminoheptane. From Vigne and Frelin (Vigne and Frelin, 2008).
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2017). The recent REPAIR clinical trial (MacAllister et al., 
2015), which is currently the largest clinical study, has provided 
evidence that RIPC improves the glomerular filtration rate 
after kidney transplantation. These encouraging results have 
motivated clinicians to look for pharmacological conditioning 
agents (preconditioners), which reproduce the benefit conferred 
by RIPC. Model organisms, such as drosophila, could help 
uncover new paradigms and new pathways involved in ischemic 
protection, possibly leading to innovative therapeutic strategies 
in the future. The use of animal models to examine conditioning 
strategies against ischemic injury is reasonable given that 
almost all organisms on earth live by virtue of the oxygen. 
Thus it could be reasonably hypothesized that evolution could 
have selected some common or similar molecular mechanisms 
concerning the management of oxygen restriction between 
species. 
Emergence of a new concept in hypoxic tolerance 
The team of Dr. C. Frelin was a pioneer in this matter and 
deciphered in drosophila a unique pathway involved in 
hypoxic tolerance. Starting from their own data demonstrating 
that restriction of dietary proteins dramatically increased the 
longevity of hypoxic flies (Vigne and Frelin, 2006; 2007; Vigne 
et al., 2009), they succeeded in identifying the mechanism 
involved in the diet dependent hypoxic tolerance. First, by 
exposing the flies to a 10% sucrose diet supplemented with 
an incremental concentration load of proteins by the addition 
of yeast or casein, they observed a dose dependent inhibitory 
action of yeast and casein on the longevity of flies maintained 
in hypoxic conditions (Vigne and Frelin, 2008). Then trying to 
understand which amino acid was responsible for the negative 
effect on survival to hypoxia, they found that any one of the 
natural amino acids could reproduce the action of yeast or 
casein at the millimolar level. This last observation suggested 
that amino acids act through a more general metabolic pathway. 
Since the common catabolic amino-acid pathway leading to 
nitrogen wasting is the urea cycle (Figure 1), Vigne and Frelin 
(2008) further examined the possible involvement of this 
pathway in hypoxic tolerance. They supplemented the 10% 
sucrose diet with L-citrulline or L-ornithine, 2 amino acids 
intermediates of the urea cycle, which are not incorporated into 
proteins. Subjecting flies fed this diet to hypoxic challenges 
revealed that both L-citrulline and L-ornithine reproduced the 
effects of individual amino acids confirming the involvement of 
the urea cycle in the susceptibility to hypoxia. Since L-ornithine 
is known to feed the polyamine synthesis pathway, they then 
tested the effect of the polyamines putrescine, spermine, and 
spermidine and showed that when added to the sucrose diet, 
these polyamines also decreased the mean longevities of 
hypoxic flies.
As highlighted in Figure 1, the first step in the synthesis 
of polyamines is the decarboxylation of L-ornithine to give 
putrescine via the action of ornithine decarboxylase (ODC) 
(Kahana, 2018). α-Difluoromethylornithine (DFMO), a 
specific inhibitor of ODC (LoGiudice et al., 2018), increased 
the median and maximum longevities of hypoxic flies fed the 
deleterious diet enriched in casein, L-asparagin, or L-ornithine. 
As DFMO reversed the life-shortening effect of amino acids, 
it confirmed the involvement of polyamines. This involvement 
was substantiated by the fact that DFMO could not preserve 
the longevity of hypoxic flies fed a sucrose diet supplemented 
with putrescine or spermidine (Vigne and Frelin, 2008). 
Polyamines exert numerous and essential cell functions (Pegg, 
2016), including the activation of the eukaryotic translation 
initiation factor eIF5A through the addition of hypusine, which 
is transferred from spermidine to a specific lysine moiety via 
the catalytic activity of deoxyhypusine synthase (DHS) and 
the subsequent action of deoxyhypusine hydroxylase (DOHH) 
(Figure 1) (Park, 2006). By using the specific DHS competitive 
inhibitor N1-guanyl-1,7-diaminoheptane (GC7) Vigne and 
Frelin (2008) showed that inhibition of DHS dramatically 
enhanced the longevity of hypoxic flies fed a diet containing 
amino acids or polyamines. Overall, the conclusion drawn 
from their research was that inhibition of eIF5A hypusination is 
crucial for promoting hypoxic tolerance (Figure 1).
A successful translation of the concept rose from a model 
organism to an integrative mammalian model of ischemia 
eIF5A is the only known protein to contain the unusual amino 
acid hypusine [N (ε)- (4-amino-2-hydroxybutyl)-lysine], 
Figure 2: Schema of the translation of the concept that arose from a model organism to an integrative mammalian model of ischemia. In 
vitro analysis of the effects of GC7 was performed on mouse cultured proximal cells. Preconditioning with GC7 provided tolerance to anoxia 
accompanied by a fall in oxidative phosphorylation (OxPhos), a fall in oxygen consumption, a fall in reactive oxygen species (ROS) generation, 
and by a metabolic switch toward anaerobic glycolysis to maintain the energetic status of the cells. In vivo analysis was performed on a 
unilateral model of kidney ischemia in rats. A 40 min blood flux arrest induced an alteration of renal function that was largely prevented at 
the structural (NGAL) and functional level (FE glucose) by preconditioning the animals with GC7. Reproduced from Melis et al. (2017).
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which is synthetized on eIF5A at a specific lysine residue 
from the polyamine spermidine. eIF5A, DHS, and DOHH 
are found in all eukaryotes and are highly conserved through 
evolution, suggesting a crucial function of eIF5A and the 
deoxyhypusine/hypusine modification (Park, 2006). It therefore 
seemed interesting to take advantage of the universal need in 
animal species for oxygen to try to translate and expand the 
data obtained in drosophila to a more integrated mammalian 
system. For this matter, the choice of kidney as a reporter organ 
either in vitro or in vivo seemed relevant since its functional 
integrity is highly dependent on the oxygen level (Hansell et 
al., 2013). For the first time using cultured cells from mouse 
proximal tubule (Duranton et al., 2012) subjected to strong 
hypoxia, we showed that GC7, as well as siRNA targeting DHS 
or DOHH, was able to largely prevent the anoxia induced cell 
death. This tolerance to ischemia was shown to follow a fall in 
oxygen consumption originating from a reversible oxidative 
phosphorylation (OxPhos) shutdown with the energetic status 
being maintained by a metabolic shift toward anaerobic 
glycolysis (Melis et al., 2017). The main consequence of this 
mitochondria "silencing" was the prevention of reactive oxygen 
species (ROS) generation. Based on these results, the authors 
performed a functional analysis of renal function in rats whose 
kidneys were subjected to the classical unilateral ischemia/
reperfusion challenge (Kato et al., 2014). GC7 preconditioning 
of these rats induced a drastic reduction in the hypusinated 
form of eIF5A as shown by western blot analysis of kidneys. 
Twenty-four hours after the ischemia/reperfusion challenge, the 
main renal parameters were checked by individual clearance 
analysis and compared in each animal to those obtained from 
the contralateral non-ischemic kidney (Melis et al., 2017). 
Concentrations of urinary neutrophil gelatinase-associated 
lipocalin (NGAL), an early marker of renal injury, significantly 
increased in the ischemic kidney together with an increase in 
sodium, glucose, and phosphate fractional excretion (FEs). GC7 
preconditioning prevented the increase in urine levels of NGAL. 
Furthermore, GC7 largely protected proximal tubular function, 
since the FEs of glucose, PO4
3−, and Na+ remained similar to 
those observed in the control non-ischemic kidney (Figure 2). 
These observations identified an innovative HIF-independent 
pathway involved in hypoxic and ischemic tolerance that 
originally emerged from the drosophila model.
The perspective of a clinical translation in kidney 
transplantation
As an experimental model, transplantation is obviously the 
best for predictable ischemic injury and evaluation of new 
protective concepts. From a clinical point of view, due to 
the success and the progress in transplantation science, the 
demand for organs continuously increases leading to longer 
wait time on transplantation waiting lists. This issue could be 
partially overcome through the extension of donor criteria and 
the acceptance of marginal donors (Rosengard et al., 2002). 
Organs, specifically kidneys from this specific population 
are particularly sensitive to ischemia reperfusion injury and 
up to now have been eliminated from the pool of available 
organs. Improving or innovating preconditioning protocols 
will enhance this pool by favorably broadening the inclusion 
criteria. To explore this kind of concept we tested the use of 
GC7 in a relevant preclinical model of kidney transplantation 
in pigs (Giraud et al., 2011; Melis et al., 2017). In this model, 
the ischemia reperfusion alone induced early and late graft 
dysfunction, whereas preconditioning of the donor with GC7 
improved graft functional recovery and late graft function 
as assessed by measurements of creatininemia, sodium FE, 
osmolarity plasma/urine, alanine aminopeptidase excretion, 
and plasma aspartate aminotransferase level. A major finding 
was the recovery of diuresis that lasted 3 days in vehicle treated 
animals whereas it was effective one day post-transplantation 
in GC7-preconditioned pigs. Additionally the use of GC7 
lowers the oxidative stress measured on biopsies post-surgery. 
At longer time points GC7 efficiently protected against the 
development of chronic interstitial fibrosis 3 months post-
transplantation. Data also showed that GC7 exposure had a 
Figure 3: Schema of the preclinical use of GC7 in kidney transplantation. The donor pig was preconditioned with GC7 before kidney removal. 
Preservation and transplantation followed a classical protocol used in the human clinic. GC7 preconditioned animals recovered a normal 
diuresis earlier than control animals. The plasma creatinine level in GC7 preconditioned animals remained below control animals up to 3 
months post transplantation confirmed the protective effect of GC7 on the graft. GC7 also prevented the increase in the oxidative stress level 
and the development of fibrosis. R60 is the time 60 min after reperfusion. Reproduced from Melis et al.  (2017).
REVIEW ARTICLE
Conditioning Medicine 2019 | www.conditionmed.org
Conditioning Medicine | 2019, 2(2):69-74
73
long–term protective effect on the graft against the inhibition 
of fibrinolysis in the vessels known to promote fibrosis. 
Furthermore the expression of the fibrosis–related factor 
(Brigstock, 2010), connective tissue growth factor (CTGF), was 
suppressed in the GC7-preconditioned group. It appears clearly 
that GC7 preconditioning improves graft function outcome in 
kidney transplantation (Figure 3).  
Conclusion
It has been demonstrated that the intensity of ischemic-
reperfusion injury very strongly correlates with delayed graft 
function, chronic graft dysfunction, and late graft loss. This 
situation places ischemic injury at the forefront of issues to be 
addressed in transplantation. Preconditioning is evidently an 
attractive and promising way to prepare the candidate organ 
for the harmful stress of oxygen deprivation (Veighey and 
MacAllister, 2017). A protocol of ischemic preconditioning 
consists of the application of brief nonlethal periods of ischemia 
that activate an innate response that confers protection against 
future potentially lethal periods of ischemia (Veighey and 
MacAllister, 2017; Veighey, 2018). Deriving from the original 
concept of ischemic preconditioning, various conditioning 
paradigms including pharmacological preconditioning may 
be promising as innovative therapies for prevention of 
ischemic-related injury like transplantation. The data reported 
in the literature shows that GC7 is an efficient cell and organ 
preconditioner against ischemia. GC7-preconditioning 
involves the inhibition of the activation step of eIF5A that 
appears to be a promising target for organ transplantation. 
Observed first in drosophila, targeting this innovative target is 
important for conferring ischemic tolerance in mammals and 
by extension, of potential use in clinical situations in which a 
fall in oxygen delivery is involved. This could serve as a basis 
from which to launch further investigation into therapies for 
organ transplantation or any other predictable ischemia related 
injuries. One future avenue of examination in to preconditioning 
strategies (Tauskela and Blondeau, 2018) would be selecting 
combinations of therapies, including different preconditioning 
protocols that likely act through different pathways to obtain 
synergistic action with a better outcome of graft function.
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